Target intelligence / Profile preview

Immune cells via paracrine factors

Molecular classification
Other
01

Overview

Immune cells via paracrine factors refers to the complex intercellular communication network where immune cells influence neighboring cells through the secretion of soluble signaling molecules such as cytokines, chemokines, and growth factors (Janeway's Immunobiology, 9th Ed.). This process is fundamental to the coordination of the immune response, allowing for localized activation, recruitment, and regulation of various cell types without requiring direct cell-to-cell contact. In pathological states like chronic inflammation or the tumor microenvironment, paracrine signaling can become dysregulated, promoting disease progression, tissue damage, or immune evasion (Nature Reviews Cancer, 2021). While the phrase itself does not represent a single molecular target, it encompasses a wide array of therapeutic targets, including specific interleukins and their receptors. Drugs often target specific components of this system, such as TNF-alpha or IL-6, to treat conditions ranging from rheumatoid arthritis to life-threatening cytokine storms (NEJM, 2018).

Other names
Paracrine immune signalingImmune cell paracrine regulationCytokine-mediated paracrine signalingIntercellular immune communication
02

Mechanism of action

Modulation of immune cell activity through the secretion and reception of local signaling molecules such as cytokines and chemokines. Therapeutic intervention typically involves using monoclonal antibodies or small molecules to inhibit specific paracrine factors or their receptors to disrupt pathological immune communication.

03

Biological functions

Immune responseSignal transductionCell-cell communicationInflammationCell recruitment
04

Disease associations

CancerInflammationAutoimmune diseaseInfectionCytokine release syndrome
05

Safety considerations

Cytokine release syndrome (CRS)Severe immunosuppressionIncreased susceptibility to opportunistic infectionsAutoimmune reactionsInfusion-related reactions
06

Interacting drugs

Tocilizumab

5 more in the full profile.

07

Biomarkers

Interleukin-6 (IL-6)Tumor Necrosis Factor-alpha (TNF-α)C-reactive protein (CRP)Interferon-gamma (IFN-γ)Interleukin-1 beta (IL-1β)

Beyond the preview

Go deeper on Immune cells via paracrine factors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune cells via paracrine factors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call